Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 24, 2014
 
Register | Sign in
Home Page>Products
  Product News
Thermo Fisher Showcases New Product Innovations and Best Practices to Optimize Stem Cell Discoveries at ISSCR 2014
Monday, June 23, 2014
Enabling engineering, expansion, differentiation, characterization, cryopreservation and ultra-cold chain to drive drug discovery applications.

Bio-Rad Introduces a Compact Biosafety System for the S3™ Cell Sorter
Monday, June 23, 2014
The system adheres to the biosafety requirements of the International Society for Advancement of Cytometry (ISAC) and protects users and the environment from aerosols created during the cell sorting process.

Leti and Akrivis Develop Nanomedicine Platform for High Payload Targeted Drug Delivery
Saturday, June 21, 2014
New theranostic platform will combine ultrasensitive detection, high payloads and more efficient cell targeting.

Determination of PAHs in Environmental Waters
Saturday, June 21, 2014
A high-performance liquid chromatography method to determine polycyclic aromatic hydrocarbons in tap water.

New Webinar on Improving Process Development Timelines with Mini Bioreactors
Saturday, June 21, 2014
Details fermentation and bioprocessing data generated by ambr250.

Agilent Introduces Novel Synthetic Biology System
Saturday, June 21, 2014
QuikChange HT system accelerates protein engineering.

Easy-to-Understand Introduction to CHN Microanalysis
Saturday, June 21, 2014
A video introduction to Model 440 microanalysis system from Exeter Analytical.

Agilent Introduces Innovative LC Columns, Biocolumns
Saturday, June 21, 2014
New Glycan mapping and small-molecule Poroshell HPH columns target challenging biotherapeutic research, high-performance pH applications.

Bioo Scientific Releases Sciclone and Biomek Protocols
Saturday, June 21, 2014
Protocols designed to eliminate NGS library prep bottlenecks.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10352
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv